Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04540887 · ClinicalTrials.gov registry record · NA

PEMF Therapy to Treat Interstitial Cystitis/Bladder Pain Syndrome

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT04540887 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04540887, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this study is to gather information from the investigation of a non-pharmacological (non-drug) treatment known as low frequency pulsed electromagnetic field (PEMF). The study team will be distributing the PEMF therapy to female subjects with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) to measure its ability to decrease pelvic pain. The results, from multiple questionnaires and voiding diaries, will be compared when participants are enrolled for treatment, at 4 weeks after using PEMF therapy, and 12 weeks post-enrollment.

Interventions

  • DEVICE Pulsed Electromagnetic Field (PEMF) Therapy

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2021-02-24
Est. Completion 2021-11-30
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT04540887

The ClinicalTrials.gov registry entry for NCT04540887 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Pulsed Electromagnetic Field (PEMF) Therapy is the first listed.

NCT04540887 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04540887 about?

NCT04540887 is a clinical study titled "PEMF Therapy to Treat Interstitial Cystitis/Bladder Pain Syndrome". The purpose of this study is to gather information from the investigation of a non-pharmacological (non-drug) treatment known as low frequency pulsed electromagnetic field (PEMF). The study team will be distributing the PEMF therapy to female subjects with Interstitial Cystitis/Bladder Pain Syndrome...

What is the current status of trial NCT04540887?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-02-24. Estimated completion is 2021-11-30.

What interventions are being tested in trial NCT04540887?

The interventions under investigation include: Pulsed Electromagnetic Field (PEMF) Therapy (DEVICE).

Who is sponsoring clinical trial NCT04540887?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.